Aclarubicin treatment restores SMN levels to cells derived from type I spinal muscular atrophy patients

Author: Androphy E.  

Publisher: Oxford University Press

ISSN: 1460-2083

Source: Human Molecular Genetics, Vol.10, Iss.24, 2001-11, pp. : 2841-2849

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract